Learn More
Medchemexpress LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG

Supplier: Medchemexpress LLC HY11734810MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in neural differentiation research. It is a small-molecule benzamide derivative (C16H14N4O2S; MW 326.37 g/mol; CAS 1316652-41-1) supplied as a solid with documented purity and batch COA.
- Selective HDAC8 inhibitor useful for neural differentiation studies.
- Batch-specific purity reported at 99.3% (COA).
- Available as a small 10 MG solid suitable for research-scale experiments.
- Solid stable at -20°C for up to 3 years; solvent solutions require colder storage.
- Comes with COA, SDS, and product datasheet for quality and safety information.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.